OPKO Health, Inc. (NASDAQ:OPK) has a beta value of 1.76 and has seen 3,570,830 shares traded in the recent trading session. The company, currently valued at $2.65 Billion, closed the recent trade at $3.93 per share which meant it lost -$0.16 on the day or -3.79% during that session. The OPK stock price is -64.63% off its 52-week high price of $6.47 and 68.19% above the 52-week low of $1.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.21 Million shares traded. The 3-month trading volume is 7.79 Million shares.
The consensus among analysts is that OPKO Health, Inc. (OPK) is a Buy stock at the moment, with a recommendation rating of 1.8. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 5 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.02.
OPKO Health, Inc. (NASDAQ:OPK) trade information
Despite being -3.79% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Apr 28 when the OPK stock price touched $4.30-8 or saw a rise of 8.49%. Year-to-date, OPKO Health, Inc. shares have moved -0.38%, while the 5-day performance has seen it change -7.85%. Over the past 30 days, the shares of OPKO Health, Inc. (NASDAQ:OPK) have changed -10.16%. Short interest in the company has seen 78.73 Million shares shorted with days to cover at 10.11.
Wall Street analysts have a consensus price target for the stock at $8.25, which means that the shares’ value could jump 109.92% from the levels at last check today. The projected low price target is $6.5 while the price target rests at a high of $10. In that case, then, we find that the latest price level in today’s session is +154.45% off the targeted high while a plunge would see the stock lose 65.39% from the levels at last check today.
OPKO Health, Inc. (OPK) estimates and forecasts
Figures show that OPKO Health, Inc. shares have outperformed across the wider relevant industry. The company’s shares have lost -2.62% over the past 6 months, with this year growth rate of 80%, compared to 22.1% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are -60% and -100% for the next quarter. Revenue growth from the last financial year stood is estimated to be +27.3%.
5 analysts offering their estimates for the company have set an average revenue estimate of $459.8 Million for the current quarter. 5 have an estimated revenue figure of $412.59 Million for the next quarter concluding in September 01, 2021. Year-ago sales stood $245.6 Million and $376.42 Million respectively for this quarter and the next, and analysts expect sales will grow by 87.2% for the current quarter and 9.6% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +22.7% over the past 5 years. Earnings growth for 2021 is a modest +109% while over the next 5 years, the company’s earnings are expected to increase by 12%.
OPKO Health, Inc. (NASDAQ:OPK)’s Major holders
Insiders own 40.21% of the company shares, while shares held by institutions stand at 29.1% with a share float percentage of 48.67%. Investors are also buoyed by the number of investors in a company, with OPKO Health, Inc. having a total of 323 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 37.63 Million shares worth more than $148.63 Million. As of December 30, 2020, Blackrock Inc. held 5.61% of shares outstanding.
The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 34.45 Million shares as of December 30, 2020. The firm’s total holdings are worth over $136.08 Million and represent 5.14% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. As of March 30, 2021, the former fund manager holds about 1.65% shares in the company for having 11070066 shares of worth $47.49 Million while later fund manager owns 10.48 Million shares of worth $41.41 Million as of December 30, 2020, which makes it owner of about 1.56% of company’s outstanding stock.